JPRN-jRCT2080221271未知3 期
DD-723 Phase III Clinical Trial - Confirmatory Study in Subjects with Suspected Prostate Cancer
DAIICHISANKYO Co.,Ltd.0 个研究点目标入组 120 人开始时间: 2010年10月19日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- Male
入选标准
- •Subjects with suspected prostate cancer who are undergoing prostate biopsy.
- •- Subjects whose most recent PSA level is between 20.0 ng/mL and 4.0 ng/mL.
- •- Subjects aged >=20 years old at the time of informed consent.
排除标准
- •- Items listed in the package insert (including absolute contraindications, careful administration, and precautions) to ensure safety.
- •- Items related to safety and ethics.
- •- Items related to surgery, procedures, and treatment that are considered likely to influence assessment of the efficacy and safety of DD-723.
研究者
相似试验
未知
3 期
DD-723 Phase III Clinical Trial (Breast)JPRN-jRCT2080221250DAIICHISANKYO Co.,Ltd.120
未知
2 期
DD-723 Phase II clinical trial (Breast)Patients with breast tumorJPRN-jRCT2080220863DAIICHISANKYO Co.,Ltd.75
未知
1 期
Phase I Clinical Trial of DS-7423JPRN-jRCT2080221724DAIICHISANKYO Co.,Ltd.27
未知
2 期
DD-723 Phase II clinical trial (Prostate)Patients with suspected prostate cancerJPRN-jRCT2080220862DAIICHISANKYO Co.,Ltd.75
未知
3 期
Phase 3 Clinical Trial with MD-0901JPRN-jRCT2080222425MOCHIDA PHARMACEUTICAL CO., LTD.250